# Pharmacokinetic Characteristics and Anti-Inflammatory Effects of Aprepitant In HIV-Infected Subjects

> **NCT02154360** · PHASE1 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 12 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Aprepitant

## Key facts

- **NCT ID:** NCT02154360
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2015-12
- **Final completion:** 2016-06
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02154360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02154360, "Pharmacokinetic Characteristics and Anti-Inflammatory Effects of Aprepitant In HIV-Infected Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02154360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*